Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells
- 1 March 2008
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 108 (3), 632-640
- https://doi.org/10.1016/j.ygyno.2007.11.034
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Management of Ovarian Stromal Cell TumorsJournal of Clinical Oncology, 2007
- Tumor necrosis factor-related apoptosis inducing ligand expression and activity in hen granulosa cellsReproduction, 2007
- Synergistic Induction of Apoptosis by the Combination of TRAIL and Chemotherapy in Chemoresistant Ovarian Cancer CellsGynecologic Oncology, 2001
- Locoregional Apo2L/TRAIL Eradicates Intracranial Human Malignant Glioma Xenografts in Athymic Mice in the Absence of NeurotoxicityBiochemical and Biophysical Research Communications, 1999
- Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivoNature Medicine, 1999
- TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κBImmunity, 1997
- Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy ReceptorsScience, 1997
- An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAILScience, 1997
- The Receptor for the Cytotoxic Ligand TRAILScience, 1997
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995